Celon Pharma S.A. nominated for the Master of the Stock Exchange award

A list of 16 companies nominated for the award was composed by the journalists and analysts of “Puls Biznesu” and the Bankier.pl platform. According to Puls Biznesu, Celon Pharma S.A. is one of the eight front runners.

The nomination justification especially pointed out the Company’s success associated with its début on the stock exchange in 2016 and the rapid growth of share prices – by as much as 50% compared to the issue price.

The readers of pb.pl and bankier.pl will decide who will receive the award at the Giełdowa Spółka Roku 2016 (Stock-Listed Company of the Year 2016) gala in March. The companies were divided into 8 pairs but only those with a higher number of votes will move up to the next phase. You can vote for Celon Pharma S.A. between 29 and 30 December until 6:00 p.m.